Review article: A practical approach to persistent gastrointestinal symptoms in inflammatory bowel disease in remission
Authors:
- Arta AliuAAArta Aliu
- Daan H. C. A. BoschDBDaan H. C. A. Bosch
- Daniel KeszthelyiDKDaniel Keszthelyi
- Ashkan Rezazadeh ArdabiliAAAshkan Rezazadeh Ardabili
- Jean‐Frederic ColombelJCJean‐Frederic Colombel
- Hans TörnblomHTHans Törnblom
- Ailsa HartAHAilsa Hart
- Daisy M. A. E. JonkersDJDaisy M. A. E. Jonkers
- Marieke J. PierikMPMarieke J. Pierik
- Zlatan MujagicZMZlatan Mujagic
Open Access
- 8 April 2024
- journal article
- review article
- Published by Wiley in Alimentary Pharmacology & Therapeutics
- Vol. 59 (12) , 1470-1488
Abstract
Summary: Background: Persistent gastrointestinal symptoms are prevalent in adult patients with inflammatory bowel disease (IBD), even when endoscopic remission is reached. These symptoms can have profound negative effects on the quality of life of affected patients and can be difficult to treat. They may be caused by IBD‐related complications or comorbid disorders, but they can also be explained by irritable bowel syndrome (IBS)‐like symptoms.Aims: To provide a practical step‐by‐step guide to diagnose and treat persistent gastrointestinal symptoms in patients with IBD in remission via a personalised approach.Methods: We scrutinised relevant literature on causes, diagnostics and treatment of persistent gastrointestinal symptoms (abdominal pain or discomfort, bloating, abdominal distension, diarrhoea, constipation and faecal incontinence) in patients with IBD in remission.Results: A graphical practical guide for several steps in diagnosing, identifying potential triggers and adequate treatment of persistent gastrointestinal symptoms in IBD in remission is provided based on supporting literature. The first part of this review focuses on the diagnostic and treatment approaches for potential IBD‐related complications and comorbidities. The second part describes the approach to IBS‐like symptoms in IBD in remission.Conclusions: Persistent gastrointestinal symptoms in IBD in remission can be traced back to potential pathophysiological mechanisms in individual patients and can be treated adequately. For both IBD‐related complications and comorbidities and IBS‐like symptoms in IBD in remission, pharmacological, dietary, lifestyle or psychological treatments can be effective. A systematic and personalised approach is required to reduce the burden for patients, healthcare systems, and society.Keywords
This publication has 159 references indexed in Scilit:
- Guideline for the diagnosis and treatment of Faecal Incontinence—A UEG/ESCP/ESNM/ESPCG collaborationUnited European Gastroenterology Journal, 2022
- A trial‐based economic evaluation of peppermint oil for the treatment of irritable bowel syndromeUnited European Gastroenterology Journal, 2021
- Systematic review: Pelvic floor muscle training for functional bowel symptoms in inflammatory bowel diseaseJGH Open, 2019
- Fecal calprotectin is a surrogate marker for endoscopic lesions in inflammatory bowel diseaseInflammatory Bowel Diseases, 2012
- Bile acid malabsorption in inflammatory bowel diseaseInflammatory Bowel Diseases, 2011
- Thiopurine therapy in inflammatory bowel disease patients: Analyses of two 8-year intercept cohortsInflammatory Bowel Diseases, 2010
- Duloxetine in the treatment of irritable bowel syndrome: an open‐label pilot studyHuman Psychopharmacology: Clinical and Experimental, 2009
- Assessment of the extension and the inflammatory activity in Crohn’s disease: comparison of ultrasound and MRIAbdominal Radiology, 2008
- A Brief Measure for Assessing Generalized Anxiety DisorderArchives of internal medicine (1960), 2006
- Ultrasonographic detection of intestinal complications in Crohn's diseaseDigestive Diseases and Sciences, 1996